Clinical application of MRI in ophthalmology

NMR in Biomedicine

Volumn 21, Issue 9, 2008, Pages 997-1002

  Townsend, Kelly A ^a   Wollstein, Gadi ^a   Schuman, Joel S ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Clinical use; Eye; MRI; Ophthalmology; Optic nerve; Retina

Indexed keywords

EYE PROTECTION; GADOLINIUM; IMAGE ENHANCEMENT; OXYGEN; PHYSIOLOGICAL MODELS;

CLINICAL USE; EYE; MRI; OPTIC NERVE; RETINA;

OPHTHALMOLOGY;

GADOLINIUM PENTETATE; MANGANESE CHLORIDE;

COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; EYE DISEASE; FLUORINE NUCLEAR MAGNETIC RESONANCE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; NEUROOPHTHALMOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OPEN ANGLE GLAUCOMA; OPTIC NERVE DISEASE; OPTIC NERVE TUMOR; PRIMARY GLAUCOMA; PRIORITY JOURNAL; RETINA DETACHMENT; RETINOBLASTOMA; REVIEW; SIGNAL NOISE RATIO; TREATMENT INDICATION; UVEA MELANOMA; UVEA TUMOR;

CONTRAST MEDIA; GADOLINIUM DTPA; HUMANS; MAGNETIC RESONANCE IMAGING; OPHTHALMOLOGY;

EID: 57149137365     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1247     Document Type: Review

References (34)

1. Atlas S, Galetta S. The orbit and visual system. In Magnetic Resonance Imaging of the Brain and Spine, Atlas S (ed). Raven Press: New York, 1991.
2. Harms S. The orbit. In Clinical Magnetic Resonance Imaging, Edelman R, Hesselink J (eds). WB Saunders: Philadelphia, 1990.
3. Sobel D, Mills C, Char D, Norman D, Brant-Zawadski M, Kaufman L, Crooks L. NMR of the normal and pathologic eye and orbit. American Journal of Neuroradiology 1984; 5: 345-350.
4. De Potter P, Shields JA, Shields CA (eds). MRI of the Eye and Orbit. J.B. Lippincott Company: Philadelphia, PA, 1995; 304.
5. de Graaf P, Knol DL, Moll AC, Imhof SM, Schouten-van Meeteren AY, Castelijns JA. Eye size in retinoblastoma: MR imaging measurements in normal and affected eyes. Radiology 2007; 244(1): 273-280.
6. Bilaniuk LT, Schenck JF, Zimmerman RA, Hart HR Jr, Foster TH, Edelstein WA, Goldberg HI, Grossman RI. Ocular and orbital lesions: surface coil MR imaging. Radiology 1985; 156(3): 669-674.
7. O'Brien JM. Retinoblastoma: clinical presentation and the role of neuroimaging. AJNR Am. J. Neuroradiol. 2001; 22(3): 426-428.
8. Wirtschafter J, Berman E, McDonald C. Magnetic Resonance Imaging and Computed Tomography, Vol. 6. American Academy of Ophthalmology: San Francisco, 1992.
9. Schenck JF, Leue W. Instrumentation: Magnets, coils, and hardware. In Magnetic Imaging of the Brain and Spine, Atlas S (ed). Raven Press: New York, 1991.
10. De Marco J, Bilaniuk LT. Magnetic resonance imaging: Technical aspects. In Radiology of the Eye and Orbit, Newton T, Bilaniuk LT (eds). Clavadel Press: San Anselmo, CA, 1990; v. 4.
11. Schmalfuss IM, Dean CW, Sistrom C, Bhatti MT. Optic neuropathy secondary to cat scratch disease: distinguishing MR imaging features from other types of optic neuropathies. AJNR Am. J. Neuroradiol. 2005; 26(6): 1310-1316.
12. Bert RJ, Patz S, Ossiani M, Caruthers SD, Jara H, Krejza J, Freddo T. High-resolution MR imaging of the human eye 2005. Acad. Radiol. 2006; 13(3): 368-378.
13. Georgouli T, James T, Tanner S, Shelley D, Nelson M, Chang B, Backhouse O, McGonagle D. High-Resolution Microscopy Coil MR-Eye. Eye 2007.
14. Albers GW, Lansberg MG, Norbash AM, Tong DC, O'Brien MW, Woolfenden AR, Marks MP, Moseley ME. Yield of diffusion-weighted MRI for detection of potentially relevant findings in stroke patients. Neurology 2000; 54(8): 1562-1567.
15. Shen Q, Cheng H, Pardue MT, Chang TF, Nair G, Vo VT, Shonat RD, Duong TQ. Magnetic resonance imaging of tissue and vascular layers in the cat retina. J. Magn. Reson. Imaging 2006; 23(4): 465-472.
16. Villablanca P, Curran J, Arnold A, Lufkin R. Orbit and optic nerve. Top Magn. Reson. Imaging 1996; 8(2): 87-110.
17. Greenfield DS, Siatkowski RM, Glaser JS, Schatz NJ, Parrish RK 2nd. The cupped disc. Who needs neuroimaging? Ophthalmology 1998; 105(10): 1866-1874.
18. Ahmed II, Feldman F, Kucharczyk W, Trope GE. Neuroradiologic screening in normal-pressure glaucoma: study results and literature review. J. Glaucoma 2002; 11(4): 279-286.
19. Kashiwagi K, Okubo T, Tsukahara S. Association of magnetic resonance imaging of anterior optic pathway with glaucomatous visual field damage and optic disc cupping. J. Glaucoma 2004; 13(3): 189-195.
20. Tarver-Carr ME, Miller NR. Tilted optic discs visualized by magnetic resonance imaging. J. Neuroophthalmol. 2006; 26(4): 282-283.
21. Pop-Fanea L, Vallespin SN, Hutchison JM, Forrester JV, Seton HC, Foster MA, Liversidge J. Evaluation of MRI for in vivo monitoring of retinal damage and detachment in experimental ocular inflammation. Magn. Reson. Med. 2005; 53(1): 61-68.
22. Mafee MF. Ocular manifestations of cat-scratch disease: role of MR imaging. AJNR Am. J. Neuroradiol. 2005; 26(6): 1303-1304.
23. Reddy AK, Morriss MC, Ostrow GI, Stass-Isern M, Olitsky SE, Lowe LH. Utility of MR imaging in cat-scratch neuroretinitis. Pediatr Radio. 2007; 37(8): 840-843.
24. Cheng H, Nair G, Walker TA, Kim MK, Pardue MT, Thule PM, Olson DE, Duong TQ. Structural and functional MRI reveals multiple retinal layers. Proc. Natl. Acad. Sci. USA 2006; 103(46): 17525-17530.
25. Duong TQ, Ngan SC, Ugurbil K, Kim SG. Functional magnetic resonance imaging of the retina. Invest. Ophthalmol. Vis. Sci. 2002; 43(4): 1176-1181.
26. Berkowitz BA, Roberts R, Goebel DJ, Luan H. Noninvasive and simultaneous imaging of layer-specific retinal functional adaptation by manganese-enhanced MRI. Invest. Ophthalmol. Vis. Sci. 2006; 47(6): 2668-2674.
27. Ito Y, Berkowitz BA. MR studies of retinal oxygenation. Vision Res. 2001; 41(10-11): 1307-1311.
28. Trick GL, Berkowitz BA. Retinal oxygenation response and retinopathy. Prog. Retin Eye Res. 2005; 24(2): 259-274.
29. Berkowitz BA, McDonald C, Ito Y, Tofts PS, Latif Z, Gross J. Measuring the human retinal oxygenation response to a hyperoxic challenge using MRI: eliminating blinking artifacts and demonstrating proof of concept. Magn. Reson. Med. 2001; 46(2): 412-416.
30. Bert RJ, Caruthers SD, Jara H, Krejza J, Melhem ER, Kolodny NH, Patz S, Freddo TF. Demonstration of an anterior diffusional pathway for solutes in the normal human eye with high spatial resolution contrast-enhanced dynamic MR imaging. Invest. Ophthalmol. Vis. Sci. 2006; 47(12): 5153-5162.
31. Kim SH, Galban CJ, Lutz RJ, Dedrick RL, Csaky KG, Lizak MJ, Wang NS, Tansey G, Robinson MR. Assessment of subconjunctival and intrascleral drug delivery to the posterior segment using dynamic contrast-enhanced magnetic resonance imaging. Invest. Ophthalmol. Vis. Sci. 2007; 48(2): 808-814.
32. Metrikin DC, Wilson CA, Berkowitz BA, Lam MK, Wood GK, Peshock RM. Measurement of blood-retinal barrier breakdown in endotoxin-induced endophthalmitis. Invest. Ophthalmol. Vis. Sci. 1995; 36(7): 1361-1370.
33. Wollstein G, Paunescu LA, Ko TH, Fujimoto JG, Kowalevicz A, Hartl I, Beaton S, Ishikawa H, Mattox C, Singh O, Duker J, Drexler W, Schuman JS. Ultrahigh-resolution optical coherence tomography in glaucoma. Ophthalmology 2005; 112(2): 229-237.
34. Scheie H, Albert DM (eds). Textbook of Ophthalmology, 9th ed. W.B. Saunders Company: Philadelphia, 1977; 616.